Baltimore, MD, United States of America

Ge Xiao

This inventor holds 1 USPTO granted patent. Top assignee: Guilford Pharmaceuticals, Inc.. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ge Xiao. Retrieved from https://idiyas.com/inventor/ge-xiao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ge Xiao - Innovator in Pharmaceutical Chemistry

Introduction

Ge Xiao is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of pharmaceutical chemistry. His work focuses on developing innovative compounds that have potential therapeutic applications.

Latest Patents

Ge Xiao holds a patent for "Sulfonamide and carbamide derivatives of 6(5H)phenanthridinones and their uses." This invention relates to compounds, pharmaceutical compositions, and methods of using the disclosed compounds for inhibiting PARP. His innovative approach in this area showcases his commitment to advancing medical science.

Career Highlights

Ge Xiao is associated with Guilford Pharmaceuticals, Inc., where he applies his expertise in pharmaceutical development. His work has led to advancements in drug formulations and therapeutic strategies. With 1 patent to his name, he continues to contribute to the field with his research and innovations.

Collaborations

Ge Xiao has collaborated with notable colleagues, including Jia-He Li and Vincent Jacob Kalish. These partnerships enhance the research environment and foster innovation within the pharmaceutical industry.

Conclusion

Ge Xiao's contributions to pharmaceutical chemistry and his innovative patent demonstrate his dedication to improving healthcare solutions. His work continues to inspire advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…